Igniting antitumour immunity with cancer cell pyroptosis.

Activation of gasdermin-induced pyroptosis in cancer cells triggers potent antitumour immune responses with minimal toxicity.

• Why it matters: Understanding how to effectively stimulate immune responses against tumors is crucial for improving cancer therapies, especially by harnessing cell death pathways that can promote immune infiltration.
• What they did: The study reviews how gasdermins can be activated by various proteases and modifications in cancer cells, leading to pyroptosis, and examines methods like T cell granzyme delivery and small molecules to induce this process.
• The result: Inducing pyroptosis in a subset of cancer cells enhances immune cell infiltration and antitumour activity, offering promising avenues to boost immunotherapy effectiveness with tolerable side effects.